{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:26:45Z","timestamp":1790342805981,"version":"4.1.0"},"reference-count":215,"publisher":"American Association for the Advancement of Science (AAAS)","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073458"],"award-info":[{"award-number":["82073458"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173424"],"award-info":[{"award-number":["82173424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974476"],"award-info":[{"award-number":["81974476"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82221002"],"award-info":[{"award-number":["82221002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Scientific Research Program of FuRong Laboratory","award":["No. 2023SK2103"],"award-info":[{"award-number":["No. 2023SK2103"]}]},{"name":"the science and technology innovation Program of Hunan Province","award":["2021RC4013"],"award-info":[{"award-number":["2021RC4013"]}]}],"content-domain":{"domain":["spj.science.org"],"crossmark-restriction":true},"short-container-title":["Research"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p>The tricarboxylic acid (TCA) cycle is capable of providing sufficient energy for the physiological activities under aerobic conditions. Although tumor metabolic reprogramming places aerobic glycolysis in a dominant position, the TCA cycle remains indispensable for tumor cells as a hub for the metabolic linkage and interconversion of glucose, lipids, and certain amino acids. TCA intermediates such as citrate, \u03b1-ketoglutarate, succinate, and fumarate are altered in tumors, and they regulate the tumor metabolism, signal transduction, and immune environment to affect tumorigenesis and tumor progression. This article provides a comprehensive review of the modifications occurring in tumor cells in relation to the intermediates of the TCA cycle, which affects tumor pathogenesis and current therapeutic strategy for therapy through targeting TCA cycle in cancer cells.<\/jats:p>","DOI":"10.34133\/research.0351","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T12:15:20Z","timestamp":1711541720000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark_01","source":"Crossref","is-referenced-by-count":52,"title":["The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy"],"prefix":"10.34133","volume":"7","author":[{"given":"Jie","family":"Wu","sequence":"first","affiliation":[{"name":"The Department of Dermatology, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"Furong Labratory, Changsha, Hunan, China."},{"name":"Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, Hunan, China."},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Liu","sequence":"additional","affiliation":[{"name":"The Department of Dermatology, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"Furong Labratory, Changsha, Hunan, China."},{"name":"Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, Hunan, China."},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"The Department of Dermatology, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"Furong Labratory, Changsha, Hunan, China."},{"name":"Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, Hunan, China."},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Tao","sequence":"additional","affiliation":[{"name":"The Department of Dermatology, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"Furong Labratory, Changsha, Hunan, China."},{"name":"Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, Hunan, China."},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuqiu","family":"Li","sequence":"additional","affiliation":[{"name":"The Department of Dermatology, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"Furong Labratory, Changsha, Hunan, China."},{"name":"Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, Hunan, China."},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"The Department of Dermatology, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"Furong Labratory, Changsha, Hunan, China."},{"name":"Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, Hunan, China."},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[{"name":"The Department of Dermatology, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"Furong Labratory, Changsha, Hunan, China."},{"name":"Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, Hunan, China."},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7104-5490","authenticated-orcid":true,"given":"Cong","family":"Peng","sequence":"additional","affiliation":[{"name":"The Department of Dermatology, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"Furong Labratory, Changsha, Hunan, China."},{"name":"Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."},{"name":"National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, Hunan, China."},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, \rCentral South University, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a040535"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-120420-025558"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00543-5"},{"issue":"2","key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.semcancer.2022.02.002","article-title":"Targeting OXPHOS and the electron transport chain in cancer; molecular and therapeutic implications","volume":"86","author":"Greene J","year":"2022","unstructured":"Greene J, Segaran A, Lord S. Targeting OXPHOS and the electron transport chain in cancer; molecular and therapeutic implications. Semin Cancer Biol. 2022;86(Pt 2):851\u2013859.","journal-title":"Semin Cancer Biol"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2018.03.001"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.123.3191.309"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2018.12.007"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1113\/JP278810"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.02.011"},{"issue":"1","key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13046-022-02338-w","article-title":"Oncometabolites drive tumorigenesis by enhancing protein acylation: From chromosomal remodelling to nonhistone modification","volume":"41","author":"Fu Y","year":"2022","unstructured":"Fu Y, Yu J, Li F, Ge S. Oncometabolites drive tumorigenesis by enhancing protein acylation: From chromosomal remodelling to nonhistone modification. J Exp Clin Cancer Res. 2022;41(1):144.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.019"},{"issue":"3","key":"e_1_3_2_14_2","first-page":"162","article-title":"Determiners of cell fates: The tricarboxylic acid cycle versus the citrate-malate shuttle","volume":"14","author":"Guo D","year":"2023","unstructured":"Guo D, He H, Meng Y, Luo S, Lu Z. Determiners of cell fates: The tricarboxylic acid cycle versus the citrate-malate shuttle. Protein Cell. 2023;14(3):162\u2013164.","journal-title":"Protein Cell"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2017.06.008"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2011.12.009"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drup.2016.09.003","article-title":"The reduced concentration of citrate in cancer cells: An indicator of cancer aggressiveness and a possible therapeutic target","volume":"29","author":"Icard P","year":"2016","unstructured":"Icard P, Lincet H. The reduced concentration of citrate in cancer cells: An indicator of cancer aggressiveness and a possible therapeutic target. Drug Resist Updat. 2016;29:47\u201353.","journal-title":"Drug Resist Updat"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nor087"},{"issue":"2","key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.mpa.0000153326.69816.7d","article-title":"Enhanced citrate synthase activity in human pancreatic cancer","volume":"30","author":"Schlichtholz B","year":"2005","unstructured":"Schlichtholz B, Turyn J, Goyke E, Biernacki M, Jaskiewicz K, Sledzinski Z, Swierczynski J. Enhanced citrate synthase activity in human pancreatic cancer. Pancreas. 2005;30(2):99\u2013104.","journal-title":"Pancreas"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/srep00785","article-title":"Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy","volume":"2","author":"Lin CC","year":"2012","unstructured":"Lin CC, Cheng TL, Tsai WH, Tsai HJ, Hu KH, Chang HC, Yeh CW, Chen YC, Liao CC, Chang WT. Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy. Sci Rep. 2012;2:785.","journal-title":"Sci Rep"},{"issue":"2","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020089","article-title":"Metabolic reprogramming in breast cancer and its therapeutic implications","volume":"8","author":"Gandhi N","year":"2019","unstructured":"Gandhi N, Das GM. Metabolic reprogramming in breast cancer and its therapeutic implications. Cells. 2019;8(2).","journal-title":"Cells"},{"issue":"10","key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1158\/0008-5472.CAN-17-2959","article-title":"Extracellular citrate affects critical elements of cancer cell metabolism and supports cancer development in\u00a0vivo","volume":"78","author":"Mycielska ME","year":"2018","unstructured":"Mycielska ME, Dettmer K, R\u00fcmmele P, Schmidt K, Prehn C, Milenkovic VM, Jagla W, Madej GM, Lantow M, Schladt M, et al. Extracellular citrate affects critical elements of cancer cell metabolism and supports cancer development in\u00a0vivo. Cancer Res. 2018;78(10):2513\u20132523.","journal-title":"Cancer Res"},{"issue":"1","key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s13046-019-1391-9","article-title":"ACLY facilitates colon cancer cell metastasis by CTNNB1","volume":"38","author":"Wen J","year":"2019","unstructured":"Wen J, Min X, Shen M, Hua Q, Han Y, Zhao L, Liu L, Huang G, Liu J, Zhao X. ACLY facilitates colon cancer cell metastasis by CTNNB1. J Exp Clin Cancer Res. 2019;38(1):401.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1359"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0567"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.01.005"},{"issue":"7381","key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10642","article-title":"Reductive carboxylation supports growth in tumour cells with defective mitochondria","volume":"481","author":"Mullen AR","year":"2011","unstructured":"Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, Yang Y, Linehan WM, Chandel NS, DeBerardinis RJ. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature. 2011;481(7381):385\u2013388.","journal-title":"Nature"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201604085"},{"issue":"7360","key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10350","article-title":"Functional genomics reveal that the serine synthesis pathway is essential in breast cancer","volume":"476","author":"Possemato R","year":"2011","unstructured":"Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011;476(7360):346\u2013350.","journal-title":"Nature"},{"issue":"3","key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0021-9258(19)44381-0","article-title":"Activation of muscle fructose 1,6-diphosphatase by creatine phosphate and citrate","volume":"248","author":"Fu JY","year":"1973","unstructured":"Fu JY, Kemp RG. Activation of muscle fructose 1,6-diphosphatase by creatine phosphate and citrate. J Biol Chem. 1973;248(3):1124\u20131125.","journal-title":"J Biol Chem"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100790","article-title":"Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?","volume":"59","author":"Icard P","year":"2021","unstructured":"Icard P, Simula L, Wu Z, Berzan D, Sogni P, Dohan A, Dautry R, Coquerel A, Lincet H, Loi M, et al. Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma? Drug Resist Updat. 2021;59: Article 100790.","journal-title":"Drug Resist Updat"},{"issue":"4","key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4149\/neo_2017_407","article-title":"FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1\u03b1","volume":"64","author":"Shi L","year":"2017","unstructured":"Shi L, He C, Li Z, Wang Z, Zhang Q. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1\u03b1. Neoplasma. 2017;64(4):535\u2013542.","journal-title":"Neoplasma"},{"issue":"1","key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbcan.2019.05.006","article-title":"Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway?","volume":"1872","author":"Grasmann G","year":"2019","unstructured":"Grasmann G, Smolle E, Olschewski H, Leithner K. Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway? Biochim Biophys Acta Rev Cancer. 2019;1872(1):24\u201336.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/s41467-017-01019-z","article-title":"Fructose-1,6-bisphosphate couples glycolytic flux to activation of Ras","volume":"8","author":"Peeters K","year":"2017","unstructured":"Peeters K, Van Leemputte F, Fischer B, Bonini BM, Quezada H, Tsytlonok M, Haesen D, Vanthienen W, Bernardes N, Gonzalez-Blas CB, et al. Fructose-1,6-bisphosphate couples glycolytic flux to activation of Ras. Nat Commun. 2017;8(1):922.","journal-title":"Nat Commun"},{"issue":"12","key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.3390\/ijms22126587","article-title":"Understanding the central role of citrate in the metabolism of cancer cells and tumors: An update","volume":"22","author":"Icard P","year":"2021","unstructured":"Icard P, Coquerel A, Wu Z, Gligorov J, Fuks D, Fournel L, Lincet H, Simula L. Understanding the central role of citrate in the metabolism of cancer cells and tumors: An update. Int J Mol Sci. 2021;22(12):6581.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00424-5"},{"issue":"5","key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.trecan.2019.03.002","article-title":"Gluconeogenesis of cancer cells is disrupted by citrate","volume":"5","author":"Icard P","year":"2019","unstructured":"Icard P, Wu Z, Alifano M, Fournel L. Gluconeogenesis of cancer cells is disrupted by citrate. Trends Cancer. 2019;5(5):265\u2013266.","journal-title":"Trends Cancer"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000903"},{"issue":"10","key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tem.2023.07.002","article-title":"The potential for citrate to reinforce epigenetic therapy by promoting apoptosis","volume":"34","author":"Icard P","year":"2023","unstructured":"Icard P, Alifano M, Simula L. The potential for citrate to reinforce epigenetic therapy by promoting apoptosis. Trends Endocrinol Metab. 2023;34(10):586\u2013589.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1757-2215-6-72","article-title":"Inhibition of Mcl-1 expression by citrate enhances the effect of Bcl-xL inhibitors on human ovarian carcinoma cells","volume":"6","author":"Lincet H","year":"2013","unstructured":"Lincet H, Kafara P, Giffard F, Abeilard-Lemoisson E, Duval M, Louis MH, Poulain L, Icard P. Inhibition of Mcl-1 expression by citrate enhances the effect of Bcl-xL inhibitors on human ovarian carcinoma cells. J Ovarian Res. 2013;6(1):72.","journal-title":"J Ovarian Res"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119355","article-title":"Citrate activates autophagic death of prostate cancer cells via downregulation CaMKII\/AKT\/mTOR pathway","volume":"275","author":"Fan X","year":"2021","unstructured":"Fan X, Zhou J, Yan X, Bi X, Liang J, Lu S, Luo L, Zhou D, Yin Z. Citrate activates autophagic death of prostate cancer cells via downregulation CaMKII\/AKT\/mTOR pathway. Life Sci. 2021;275: Article 119355.","journal-title":"Life Sci"},{"issue":"6","key":"e_1_3_2_42_2","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101993RR","article-title":"Citric acid of ovarian cancer metabolite induces pyroptosis via the caspase-4\/TXNIP-NLRP3-GSDMD pathway in ovarian cancer","volume":"36","author":"Wang X","year":"2022","unstructured":"Wang X, Yin Y, Qian W, Peng C, Shen S, Wang T, Zhao S. Citric acid of ovarian cancer metabolite induces pyroptosis via the caspase-4\/TXNIP-NLRP3-GSDMD pathway in ovarian cancer. FASEB J. 2022;36(6): Article e22362.","journal-title":"FASEB J"},{"issue":"1","key":"e_1_3_2_43_2","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101553","article-title":"Citrate promotes excessive lipid biosynthesis and senescence in tumor cells for tumor therapy","volume":"9","author":"Zhao Y","year":"2022","unstructured":"Zhao Y, Liu X, Si F, Huang L, Gao A, Lin W, Hoft DF, Shao Q, Peng G. Citrate promotes excessive lipid biosynthesis and senescence in tumor cells for tumor therapy. Adv Sci (Weinh). 2022;9(1): Article e2101553.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1038\/s41598-017-04626-4","article-title":"Citrate suppresses tumor growth in multiple models through inhibition of glycolysis, the tricarboxylic acid cycle and the IGF-1R pathway","volume":"7","author":"Ren JG","year":"2017","unstructured":"Ren JG, Seth P, Ye H, Guo K, Hanai JI, Husain Z, Sukhatme VP. Citrate suppresses tumor growth in multiple models through inhibition of glycolysis, the tricarboxylic acid cycle and the IGF-1R pathway. Sci Rep. 2017;7(1):4537.","journal-title":"Sci Rep"},{"issue":"14","key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.3390\/cancers14143355","article-title":"Extracellular citrate treatment induces HIF1\u03b1 degradation and inhibits the growth of low-glycolytic hepatocellular carcinoma under hypoxia","volume":"14","author":"Kim SY","year":"2022","unstructured":"Kim SY, Kim D, Kim J, Ko HY, Kim WJ, Park Y, Lee HW, Han DH, Kim KS, Park S, et al. Extracellular citrate treatment induces HIF1\u03b1 degradation and inhibits the growth of low-glycolytic hepatocellular carcinoma under hypoxia. Cancers (Basel). 2022;14(14):3355.","journal-title":"Cancers (Basel)"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-012-9455-y"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1743"},{"issue":"14","key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.3390\/cancers14143425","article-title":"The role of citrate homeostasis in Merkel cell carcinoma pathogenesis","volume":"14","author":"Drexler K","year":"2022","unstructured":"Drexler K, Schwertner B, Haerteis S, Aung T, Berneburg M, Geissler EK, Mycielska ME, Haferkamp S. The role of citrate homeostasis in Merkel cell carcinoma pathogenesis. Cancers (Basel). 2022;14(14):3425.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/0008-5472.CAN-22-2045","article-title":"Enhanced glutaminolysis drives hypoxia-induced chemoresistance in pancreatic cancer","volume":"83","author":"Park SJ","year":"2023","unstructured":"Park SJ, Yoo HC, Ahn E, Luo E, Kim Y, Sung Y, Yu YC, Kim K, Min DS, Lee HS, et al. Enhanced glutaminolysis drives hypoxia-induced chemoresistance in pancreatic cancer. Cancer Res. 2023;83(5):735\u2013752.","journal-title":"Cancer Res"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-061516-044724"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00303-3"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1039\/c0cs00203h"},{"issue":"1","key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emm.2004.1","article-title":"Hypoxia-inducible factor (HIF-1)\u03b1: Its protein stability and biological functions","volume":"36","author":"Lee JW","year":"2004","unstructured":"Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1)\u03b1: Its protein stability and biological functions. Exp Mol Med. 2004;36(1):1\u201312.","journal-title":"Exp Mol Med"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145796","article-title":"Up-down regulation of HIF-1\u03b1 in cancer progression","volume":"798","author":"Rashid M","year":"2021","unstructured":"Rashid M, Zadeh LR, Baradaran B, Molavi O, Ghesmati Z, Sabzichi M, Ramezani F. Up-down regulation of HIF-1\u03b1 in cancer progression. Gene. 2021;798: Article 145796.","journal-title":"Gene"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2014.07.005"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3589"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2020.12.011"},{"issue":"1","key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41392-022-01145-1","article-title":"JMJD family proteins in cancer and inflammation","volume":"7","author":"Manni W","year":"2022","unstructured":"Manni W, Jianxin X, Weiqi H, Siyuan C, Huashan S. JMJD family proteins in cancer and inflammation. Signal Transduct Target Ther. 2022;7(1):304.","journal-title":"Signal Transduct Target Ther"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1805662115"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature24294"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-0035-5"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102065","article-title":"Lactate and glutamine support NADPH generation in cancer cells under glucose deprived conditions","volume":"46","author":"Ying M","year":"2021","unstructured":"Ying M, You D, Zhu X, Cai L, Zeng S, Hu X. Lactate and glutamine support NADPH generation in cancer cells under glucose deprived conditions. Redox Biol. 2021;46: Article 102065.","journal-title":"Redox Biol"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164382"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0903840"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0473"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.2913"},{"key":"e_1_3_2_67_2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.982424","article-title":"Recent advances of IDH1 mutant inhibitor in cancer therapy","volume":"13","author":"Tian W","year":"2022","unstructured":"Tian W, Zhang W, Wang Y, Jin R, Wang Y, Guo H, Tang Y, Yao X. Recent advances of IDH1 mutant inhibitor in cancer therapy. Front Pharmacol. 2022;13: Article 982424.","journal-title":"Front Pharmacol"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov136"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.12.014"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12700"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.7b00009"},{"issue":"1","key":"e_1_3_2_72_2","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41467-017-00984-9","article-title":"Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL","volume":"8","author":"Karpel-Massler G","year":"2017","unstructured":"Karpel-Massler G, Ishida CT, Bianchetti E, Zhang Y, Shu C, Tsujiuchi T, Banu MA, Garcia F, Roth KA, Bruce JN, et al. Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL. Nat Commun. 2017;8(1):1067.","journal-title":"Nat Commun"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00532-w"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.05.012"},{"issue":"12","key":"e_1_3_2_75_2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel JP","year":"2012","unstructured":"Patel JP, G\u00f6nen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, Van Vlierberghe P, Dolgalev I, Thomas S, Aminova O, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012;366(12):1079\u20131089.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.11.031"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.06.009"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.12.026"},{"issue":"26","key":"e_1_3_2_79_2","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","author":"Eckel-Passow JE","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, et al. Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015;372(26):2499\u20132508.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2010.05.003"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1259472"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-bioeng-071516-044546"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.07.007"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-021-00506-9"},{"issue":"18","key":"e_1_3_2_85_2","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1158\/0008-5472.CAN-21-3914","article-title":"GLS2 is a tumor suppressor and a regulator of ferroptosis in hepatocellular carcinoma","volume":"82","author":"Suzuki S","year":"2022","unstructured":"Suzuki S, Venkatesh D, Kanda H, Nakayama A, Hosokawa H, Lee E, Miki T, Stockwell BR, Yokote K, Tanaka T, et al. GLS2 is a tumor suppressor and a regulator of ferroptosis in hepatocellular carcinoma. Cancer Res. 2022;82(18):3209\u20133222.","journal-title":"Cancer Res"},{"issue":"1","key":"e_1_3_2_86_2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41420-023-01475-1","article-title":"\u03b1-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis","volume":"9","author":"Cai Y","year":"2023","unstructured":"Cai Y, Lv L, Lu T, Ding M, Yu Z, Chen X, Zhou X, Wang X. \u03b1-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis. Cell Death Discov. 2023;9(1):182.","journal-title":"Cell Death Discov"},{"issue":"24","key":"e_1_3_2_87_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249406","article-title":"Alpha ketoglutarate exerts in\u00a0vitro anti-osteosarcoma effects through inhibition of cell proliferation, induction of apoptosis via the JNK and caspase 9-dependent mechanism, and suppression of TGF-\u03b2 and VEGF production and metastatic potential of cells","volume":"21","author":"Ka\u0142awaj K","year":"2020","unstructured":"Ka\u0142awaj K, S\u0142awi\u0144ska-Brych A, Mizerska-Kowalska M, \u017burek A, Bojarska-Junak A, Kandefer-Szersze\u0144 M, Zdzisi\u0144ska B. Alpha ketoglutarate exerts in\u00a0vitro anti-osteosarcoma effects through inhibition of cell proliferation, induction of apoptosis via the JNK and caspase 9-dependent mechanism, and suppression of TGF-\u03b2 and VEGF production and metastatic potential of cells. Int J Mol Sci. 2020;21(24).","journal-title":"Int J Mol Sci"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1577-5"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2906"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-3868"},{"issue":"1","key":"e_1_3_2_91_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O,Neill LA","year":"2016","unstructured":"O,Neill LA, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016;213(1):15\u201323.","journal-title":"J Exp Med"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3796"},{"issue":"2","key":"e_1_3_2_93_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110660","article-title":"SENP1-Sirt3 signaling promotes \u03b1-ketoglutarate production during M2 macrophage polarization","volume":"39","author":"Zhou W","year":"2022","unstructured":"Zhou W, Hu G, He J, Wang T, Zuo Y, Cao Y, Zheng Q, Tu J, Ma J, Cai R, et al. SENP1-Sirt3 signaling promotes \u03b1-ketoglutarate production during M2 macrophage polarization. Cell Rep. 2022;39(2): Article 110660.","journal-title":"Cell Rep"},{"issue":"5","key":"e_1_3_2_94_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109911","article-title":"Regulatory T cell differentiation is controlled by \u03b1KG-induced alterations in mitochondrial metabolism and lipid homeostasis","volume":"37","author":"Matias MI","year":"2021","unstructured":"Matias MI, Yong CS, Foroushani A, Goldsmith C, Mongellaz C, Sezgin E, Levental KR, Talebi A, Perrault J, Rivi\u00e8re A, et al. Regulatory T cell differentiation is controlled by \u03b1KG-induced alterations in mitochondrial metabolism and lipid homeostasis. Cell Rep. 2021;37(5): Article 109911.","journal-title":"Cell Rep"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature23475"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90644"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0095-6"},{"issue":"3","key":"e_1_3_2_98_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030742","article-title":"D-2-hydroxyglutarate and L-2-hydroxyglutarate inhibit IL-12 secretion by human monocyte-derived dendritic cells","volume":"20","author":"Ugele I","year":"2019","unstructured":"Ugele I, C\u00e1rdenas-Conejo ZE, Hammon K, Wehrstein M, Bruss C, Peter K, Singer K, Gottfried E, Boesch J, Oefner P, et al. D-2-hydroxyglutarate and L-2-hydroxyglutarate inhibit IL-12 secretion by human monocyte-derived dendritic cells. Int J Mol Sci. 2019;20(3).","journal-title":"Int J Mol Sci"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.10.021"},{"issue":"2","key":"e_1_3_2_100_2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41419-023-05692-5","article-title":"Supplementation with \u03b1-ketoglutarate improved the efficacy of anti-PD1 melanoma treatment through epigenetic modulation of PD-L1","volume":"14","author":"Liu N","year":"2023","unstructured":"Liu N, Zhang J, Yan M, Chen L, Wu J, Tao Q, Yan B, Chen X, Peng C. Supplementation with \u03b1-ketoglutarate improved the efficacy of anti-PD1 melanoma treatment through epigenetic modulation of PD-L1. Cell Death Dis. 2023;14(2):170.","journal-title":"Cell Death Dis"},{"issue":"27","key":"e_1_3_2_101_2","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301975","article-title":"Targeting alpha-ketoglutarate disruption overcomes immunoevasion and improves PD-1 blockade immunotherapy in renal cell carcinoma","volume":"10","author":"Li L","year":"2023","unstructured":"Li L, Zeng X, Chao Z, Luo J, Guan W, Zhang Q, Ge Y, Wang Y, Xiong Z, Ma S, et al. Targeting alpha-ketoglutarate disruption overcomes immunoevasion and improves PD-1 blockade immunotherapy in renal cell carcinoma. Adv Sci (Weinh). 2023;10(27): Article e2301975.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"e_1_3_2_102_2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s12967-023-04312-2","article-title":"Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1","volume":"21","author":"Tan H","year":"2023","unstructured":"Tan H, Liu J, Huang J, Li Y, Xie Q, Dong Y, Mi Z, Ma X, Rong P. Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1. J Transl Med. 2023;21(1):462.","journal-title":"J Transl Med"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1111\/his.13277"},{"issue":"3","key":"e_1_3_2_104_2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/PAS.0000000000001415","article-title":"Morphologic clues to succinate dehydrogenase (SDH) deficiency in pheochromocytomas and paragangliomas","volume":"44","author":"Turchini J","year":"2020","unstructured":"Turchini J, Gill AJ. Morphologic clues to succinate dehydrogenase (SDH) deficiency in pheochromocytomas and paragangliomas. Am J Surg Pathol. 2020;44(3):422\u2013424.","journal-title":"Am J Surg Pathol"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.04.001"},{"issue":"7","key":"e_1_3_2_106_2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamaoncol.2016.0256","article-title":"Molecular subtypes of KIT\/PDGFRA wild-type gastrointestinal stromal tumors: A report from the National Institutes of Health gastrointestinal stromal tumor clinic","volume":"2","author":"Boikos SA","year":"2016","unstructured":"Boikos SA, Pappo AS, Killian JK, LaQuaglia MP, Weldon CB, George S, Trent JC, von Mehren M, Wright JA, Schiffman JD, et al. Molecular subtypes of KIT\/PDGFRA wild-type gastrointestinal stromal tumors: A report from the National Institutes of Health gastrointestinal stromal tumor clinic. JAMA Oncol. 2016;2(7):922\u2013928.","journal-title":"JAMA Oncol"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2021.12.002"},{"issue":"4","key":"e_1_3_2_108_2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PAS.0000000000000149","article-title":"Succinate dehydrogenase deficiency is rare in pituitary adenomas","volume":"38","author":"Gill AJ","year":"2014","unstructured":"Gill AJ, Toon CW, Clarkson A, Sioson L, Chou A, Winship I, Robinson BG, Benn DE, Clifton-Bligh RJ, Dwight T. Succinate dehydrogenase deficiency is rare in pituitary adenomas. Am J Surg Pathol. 2014;38(4):560\u2013566.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"e_1_3_2_109_2","doi-asserted-by":"crossref","first-page":"E2063","DOI":"10.1210\/jc.2011-1616","article-title":"Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations","volume":"96","author":"Ngeow J","year":"2011","unstructured":"Ngeow J, Mester J, Rybicki LA, Ni Y, Milas M, Eng C. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. J Clin Endocrinol Metab. 2011;96(12):E2063\u2013E2071.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"e_1_3_2_110_2","doi-asserted-by":"crossref","first-page":"E1386","DOI":"10.1210\/jc.2015-2689","article-title":"Succinate dehydrogenase (SDH)-deficient pancreatic neuroendocrine tumor expands the SDH-related tumor spectrum","volume":"100","author":"Niemeijer ND","year":"2015","unstructured":"Niemeijer ND, Papathomas TG, Korpershoek E, de Krijger RR, Oudijk L, Morreau H, Bayley JP, Hes FJ, Jansen JC, Dinjens WN, et al. Succinate dehydrogenase (SDH)-deficient pancreatic neuroendocrine tumor expands the SDH-related tumor spectrum. J Clin Endocrinol Metab. 2015;100(10):E1386\u2013E1393.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"e_1_3_2_111_2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1507\/endocrj.EJ21-0630","article-title":"Colorectal paragangliomas with immunohistochemical deficiency of succinate dehydrogenase subunit B","volume":"69","author":"Kimura N","year":"2022","unstructured":"Kimura N, Ishikawa M, Shigematsu K. Colorectal paragangliomas with immunohistochemical deficiency of succinate dehydrogenase subunit B. Endocr J. 2022;69(5):523\u2013528.","journal-title":"Endocr J"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01702"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.04.019"},{"issue":"7","key":"e_1_3_2_114_2","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3390\/ijms19072129","article-title":"Succinate accumulation is associated with a shift of mitochondrial respiratory control and HIF-1\u03b1 upregulation in PTEN negative prostate cancer cells","volume":"19","author":"Weber A","year":"2018","unstructured":"Weber A, Klocker H, Oberacher H, Gnaiger E, Neuwirt H, Sampson N, Eder IE. Succinate accumulation is associated with a shift of mitochondrial respiratory control and HIF-1\u03b1 upregulation in PTEN negative prostate cancer cells. Int J Mol Sci. 2018;19(7):2129.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"e_1_3_2_115_2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouz\u00e9 E","year":"2013","unstructured":"Letouz\u00e9 E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C, Janin M, Menara M, Nguyen AT, Benit P, et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell. 2013;23(6):739\u2013752.","journal-title":"Cancer Cell"},{"issue":"20","key":"e_1_3_2_116_2","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214942120","article-title":"The PLOD2\/succinate axis regulates the epithelial-mesenchymal plasticity and cancer cell stemness","volume":"120","author":"Tong Y","year":"2023","unstructured":"Tong Y, Qi Y, Xiong G, Li J, Scott TL, Chen J, He D, Li L, Wang C, Lane AN, et al. The PLOD2\/succinate axis regulates the epithelial-mesenchymal plasticity and cancer cell stemness. Proc Natl Acad Sci USA. 2023;120(20): Article e2214942120.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"e_1_3_2_117_2","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/324413","article-title":"The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway","volume":"69","author":"Gimenez-Roqueplo AP","year":"2001","unstructured":"Gimenez-Roqueplo AP, Favier J, Rustin P, Mourad JJ, Plouin PF, Corvol P, R\u00f6tig A, Jeunemaitre X. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet. 2001;69(6):1186\u20131197.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_2_118_2","first-page":"115","article-title":"Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1\u03b1 pathway in human ovarian cancer in\u00a0vitro","volume":"7","author":"Chen L","year":"2014","unstructured":"Chen L, Liu T, Zhang S, Zhou J, Wang Y, Di W. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1\u03b1 pathway in human ovarian cancer in\u00a0vitro. J Ovarian Res. 2014;7:115.","journal-title":"J Ovarian Res"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0170-4"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2363-0"},{"issue":"9","key":"e_1_3_2_121_2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/ncb3209","article-title":"Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation","volume":"17","author":"Jiang Y","year":"2015","unstructured":"Jiang Y, Qian X, Shen J, Wang Y, Li X, Liu R, Xia Y, Chen Q, Peng G, Lin SY, et al. Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. Nat Cell Biol. 2015;17(9):1158\u20131168.","journal-title":"Nat Cell Biol"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246064"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.10.023"},{"key":"e_1_3_2_124_2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.589451","article-title":"Succinate mediates tumorigenic effects via succinate receptor 1: Potential for new targeted treatment strategies in succinate dehydrogenase deficient paragangliomas","volume":"12","author":"Matlac DM","year":"2021","unstructured":"Matlac DM, Hadrava Vanova K, Bechmann N, Richter S, Folberth J, Ghayee HK, Ge GB, Abunimer L, Wesley R, Aherrahrou R, et al. Succinate mediates tumorigenic effects via succinate receptor 1: Potential for new targeted treatment strategies in succinate dehydrogenase deficient paragangliomas. Front Endocrinol (Lausanne). 2021;12: Article 589451.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"e_1_3_2_125_2","doi-asserted-by":"crossref","first-page":"13174","DOI":"10.18632\/oncotarget.14485","article-title":"Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation","volume":"8","author":"Mu X","year":"2017","unstructured":"Mu X, Zhao T, Xu C, Shi W, Geng B, Shen J, Zhang C, Pan J, Yang J, Hu S, et al. Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation. Oncotarget. 2017;8(8):13174\u201313185.","journal-title":"Oncotarget"},{"key":"e_1_3_2_126_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2021.11.024","article-title":"Succinate receptor 1 inhibits mitochondrial respiration in cancer cells addicted to glutamine","volume":"526","author":"Rabe P","year":"2022","unstructured":"Rabe P, Liebing AD, Krumbholz P, Kraft R, St\u00e4ubert C. Succinate receptor 1 inhibits mitochondrial respiration in cancer cells addicted to glutamine. Cancer Lett. 2022;526:91\u2013102.","journal-title":"Cancer Lett"},{"key":"e_1_3_2_127_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.canlet.2019.07.001","article-title":"SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS\/NF\u03baB signaling","volume":"461","author":"Li J","year":"2019","unstructured":"Li J, Liang N, Long X, Zhao J, Yang J, Du X, Yang T, Yuan P, Huang X, Zhang J, et al. SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS\/NF\u03baB signaling. Cancer Lett. 2019;461:44\u201355.","journal-title":"Cancer Lett"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-015-1738-3"},{"key":"e_1_3_2_129_2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.biochi.2017.01.004","article-title":"Exposure to high levels of fumarate and succinate leads to apoptotic cytotoxicity and altered global DNA methylation profiles in\u00a0vitro","volume":"135","author":"Wentzel JF","year":"2017","unstructured":"Wentzel JF, Lewies A, Bronkhorst AJ, van Dyk E, du Plessis LH, Pretorius PJ. Exposure to high levels of fumarate and succinate leads to apoptotic cytotoxicity and altered global DNA methylation profiles in\u00a0vitro. Biochimie. 2017;135:28\u201334.","journal-title":"Biochimie"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr459"},{"key":"e_1_3_2_131_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2020.02.009","article-title":"Melatonin alleviates progression of uterine endometrial cancer by suppressing estrogen\/ubiquitin C\/SDHB-mediated succinate accumulation","volume":"476","author":"Gu C","year":"2020","unstructured":"Gu C, Yang H, Chang K, Zhang B, Xie F, Ye J, Chang R, Qiu X, Wang Y, Qu Y, et al. Melatonin alleviates progression of uterine endometrial cancer by suppressing estrogen\/ubiquitin C\/SDHB-mediated succinate accumulation. Cancer Lett. 2020;476:34\u201347.","journal-title":"Cancer Lett"},{"issue":"11","key":"e_1_3_2_132_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109246","article-title":"Extracellular succinate hyperpolarizes M2 macrophages through SUCNR1\/GPR91-mediated Gq signaling","volume":"35","author":"Trauelsen M","year":"2021","unstructured":"Trauelsen M, Hiron TK, Lin D, Petersen JE, Breton B, Husted AS, Hjorth SA, Inoue A, Frimurer TM, Bouvier M, et al. Extracellular succinate hyperpolarizes M2 macrophages through SUCNR1\/GPR91-mediated Gq signaling. Cell Rep. 2021;35(11): Article 109246.","journal-title":"Cell Rep"},{"issue":"652","key":"e_1_3_2_133_2","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aax4585","article-title":"Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells","volume":"13","author":"G\u00f3mez V","year":"2020","unstructured":"G\u00f3mez V, Eykyn TR, Mustapha R, Flores-Borja F, Male V, Barber PR, Patsialou A, Green R, Panagaki F, Li CW, et al. Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells. Sci Signal. 2020;13(652).","journal-title":"Sci Signal"},{"issue":"8","key":"e_1_3_2_134_2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cmet.2022.06.008","article-title":"Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells","volume":"34","author":"Elia I","year":"2022","unstructured":"Elia I, Rowe JH, Johnson S, Joshi S, Notarangelo G, Kurmi K, Weiss S, Freeman GJ, Sharpe AH, Haigis MC. Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells. Cell Metab. 2022;34(8):1137\u20131150.e1136.","journal-title":"Cell Metab"},{"issue":"7","key":"e_1_3_2_135_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111193","article-title":"Succinate uptake by T cells suppresses their effector function via inhibition of mitochondrial glucose oxidation","volume":"40","author":"Gudgeon N","year":"2022","unstructured":"Gudgeon N, Munford H, Bishop EL, Hill J, Fulton-Ward T, Bending D, Roberts J, Tennant DA, Dimeloe S. Succinate uptake by T cells suppresses their effector function via inhibition of mitochondrial glucose oxidation. Cell Rep. 2022;40(7): Article 111193.","journal-title":"Cell Rep"},{"issue":"5","key":"e_1_3_2_136_2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","article-title":"Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer","volume":"31","author":"Jiang SS","year":"2023","unstructured":"Jiang SS, Xie YL, Xiao XY, Kang ZR, Lin XL, Zhang L, Li CS, Qian Y, Xu PP, Leng XX, et al. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer. Cell Host Microbe. 2023;31(5):781\u2013797.e789.","journal-title":"Cell Host Microbe"},{"issue":"11","key":"e_1_3_2_137_2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ni.1657","article-title":"Triggering the succinate receptor GPR91 on dendritic cells enhances immunity","volume":"9","author":"Rubic T","year":"2008","unstructured":"Rubic T, Lametschwandtner G, Jost S, Hinteregger S, Kund J, Carballido-Perrig N, Schw\u00e4rzler C, Junt T, Voshol H, Meingassner JG, et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol. 2008;9(11):1261\u20131269.","journal-title":"Nat Immunol"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2018.03.012"},{"issue":"7684","key":"e_1_3_2_139_2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature25003","article-title":"KAT2A coupled with the \u03b1-KGDH complex acts as a histone H3 succinyltransferase","volume":"552","author":"Wang Y","year":"2017","unstructured":"Wang Y, Guo YR, Liu K, Yin Z, Liu R, Xia Y, Tan L, Yang P, Lee JH, Li XJ, et al. KAT2A coupled with the \u03b1-KGDH complex acts as a histone H3 succinyltransferase. Nature. 2017;552(7684):273\u2013277.","journal-title":"Nature"},{"issue":"6","key":"e_1_3_2_140_2","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.celrep.2018.01.030","article-title":"Carnitine palmitoyltransferase 1A has a lysine succinyltransferase activity","volume":"22","author":"Kurmi K","year":"2018","unstructured":"Kurmi K, Hitosugi S, Wiese EK, Boakye-Agyeman F, Gonsalves WI, Lou Z, Karnitz LM, Goetz MP, Hitosugi T. Carnitine palmitoyltransferase 1A has a lysine succinyltransferase activity. Cell Rep. 2018;22(6):1365\u20131373.","journal-title":"Cell Rep"},{"issue":"1","key":"e_1_3_2_141_2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13046-020-01681-0","article-title":"Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer","volume":"39","author":"Li X","year":"2020","unstructured":"Li X, Zhang C, Zhao T, Su Z, Li M, Hu J, Wen J, Shen J, Wang C, Pan J, et al. Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer. J Exp Clin Cancer Res. 2020;39(1):172.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"e_1_3_2_142_2","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.molcel.2021.04.002","article-title":"SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells","volume":"81","author":"Tong Y","year":"2021","unstructured":"Tong Y, Guo D, Lin SH, Liang J, Yang D, Ma C, Shao F, Li M, Yu Q, Jiang Y, et al. SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells. Mol Cell. 2021;81(11):2303\u20132316.e2308.","journal-title":"Mol Cell"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1912"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.06.001"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12235"},{"issue":"6","key":"e_1_3_2_146_2","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1021\/jacs.8b12083","article-title":"A click chemistry approach reveals the chromatin-dependent histone H3K36 deacylase nature of SIRT7","volume":"141","author":"Wang WW","year":"2019","unstructured":"Wang WW, Angulo-Ibanez M, Lyu J, Kurra Y, Tong Z, Wu B, Zhang L, Sharma V, Zhou J, Lin H, et al. A click chemistry approach reveals the chromatin-dependent histone H3K36 deacylase nature of SIRT7. J Am Chem Soc. 2019;141(6):2462\u20132473.","journal-title":"J Am Chem Soc"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi7495"},{"issue":"4","key":"e_1_3_2_148_2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson IP","year":"2002","unstructured":"Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002;30(4):406\u2013410.","journal-title":"Nat Genet"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt639"},{"issue":"6","key":"e_1_3_2_150_2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jmg.2005.036400","article-title":"Increased risk of cancer in patients with fumarate hydratase germline mutation","volume":"43","author":"Lehtonen HJ","year":"2006","unstructured":"Lehtonen HJ, Kiuru M, Ylisaukko-Oja SK, Salovaara R, Herva R, Koivisto PA, Vierimaa O, Aittom\u00e4ki K, Pukkala E, Launonen V, et al. Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet. 2006;43(6):523\u2013526.","journal-title":"J Med Genet"},{"key":"e_1_3_2_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.06.106"},{"key":"e_1_3_2_152_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature19353"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0268"},{"key":"e_1_3_2_154_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.568162"},{"issue":"1","key":"e_1_3_2_155_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2337\/db07-0838","article-title":"Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: Formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress","volume":"57","author":"Blatnik M","year":"2008","unstructured":"Blatnik M, Frizzell N, Thorpe SR, Baynes JW. Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: Formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress. Diabetes. 2008;57(1):41\u201349.","journal-title":"Diabetes"},{"key":"e_1_3_2_156_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.2932"},{"key":"e_1_3_2_157_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.09.006"},{"key":"e_1_3_2_158_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.03.022"},{"issue":"11","key":"e_1_3_2_159_2","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00079-17","article-title":"Fumarate mediates a chronic proliferative signal in fumarate hydratase-inactivated cancer cells by increasing transcription and translation of ferritin genes","volume":"37","author":"Kerins MJ","year":"2017","unstructured":"Kerins MJ, Vashisht AA, Liang BX, Duckworth SJ, Praslicka BJ, Wohlschlegel JA, Ooi A. Fumarate mediates a chronic proliferative signal in fumarate hydratase-inactivated cancer cells by increasing transcription and translation of ferritin genes. Mol Cell Biol. 2017;37(11).","journal-title":"Mol Cell Biol"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.01.029"},{"key":"e_1_3_2_161_2","first-page":"9838341","article-title":"Caspase-1 and Gasdermin D afford the optimal targets with distinct switching strategies in NLRP1b inflammasome-induced cell death","volume":"2022","author":"Li X","year":"2022","unstructured":"Li X, Zhang P, Yin Z, Xu F, Yang ZH, Jin J, Qu J, Liu Z, Qi H, Yao C, et al. Caspase-1 and Gasdermin D afford the optimal targets with distinct switching strategies in NLRP1b inflammasome-induced cell death. Research (Wash D C). 2022;2022:9838341.","journal-title":"Research (Wash D C)"},{"key":"e_1_3_2_162_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.09.092"},{"issue":"3","key":"e_1_3_2_163_2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.celrep.2013.02.013","article-title":"Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency","volume":"3","author":"Ternette N","year":"2013","unstructured":"Ternette N, Yang M, Laroyia M, Kitagawa M, O,Flaherty L, Wolhulter K, Igarashi K, Saito K, Kato K, Fischer R, et al. Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency. Cell Rep. 2013;3(3):689\u2013700.","journal-title":"Cell Rep"},{"key":"e_1_3_2_164_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2009.08.018"},{"key":"e_1_3_2_165_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.07.018"},{"issue":"7363","key":"e_1_3_2_166_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature10363","article-title":"Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase","volume":"477","author":"Frezza C","year":"2011","unstructured":"Frezza C, Zheng L, Folger O, Rajagopalan KN, MacKenzie ED, Jerby L, Micaroni M, Chaneton B, Adam J, Hedley A, et al. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature. 2011;477(7363):225\u2013228.","journal-title":"Nature"},{"issue":"1","key":"e_1_3_2_167_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2049-3002-1-12","article-title":"Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells","volume":"1","author":"Zheng L","year":"2013","unstructured":"Zheng L, MacKenzie ED, Karim SA, Hedley A, Blyth K, Kalna G, Watson DG, Szlosarek P, Frezza C, Gottlieb E. Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells. Cancer Metab. 2013;1(1):12.","journal-title":"Cancer Metab"},{"key":"e_1_3_2_168_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0874"},{"key":"e_1_3_2_169_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00483-09"},{"key":"e_1_3_2_170_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.05.003"},{"key":"e_1_3_2_171_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05770-w"},{"key":"e_1_3_2_172_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.04.017"},{"key":"e_1_3_2_173_2","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201591041"},{"key":"e_1_3_2_174_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02798-0"},{"key":"e_1_3_2_175_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12040"},{"issue":"1","key":"e_1_3_2_176_2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/s12885-018-4443-1","article-title":"Inhibition of glutamate oxaloacetate transaminase 1 in cancer cell lines results in altered metabolism with increased dependency of glucose","volume":"18","author":"Zhou X","year":"2018","unstructured":"Zhou X, Curbo S, Li F, Krishnan S, Karlsson A. Inhibition of glutamate oxaloacetate transaminase 1 in cancer cell lines results in altered metabolism with increased dependency of glucose. BMC Cancer. 2018;18(1):559.","journal-title":"BMC Cancer"},{"issue":"8","key":"e_1_3_2_177_2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1158\/0008-5472.CAN-17-3155","article-title":"ME1 regulates NADPH homeostasis to promote gastric cancer growth and metastasis","volume":"78","author":"Lu YX","year":"2018","unstructured":"Lu YX, Ju HQ, Liu ZX, Chen DL, Wang Y, Zhao Q, Wu QN, Zeng ZL, Qiu HB, Hu PS, et al. ME1 regulates NADPH homeostasis to promote gastric cancer growth and metastasis. Cancer Res. 2018;78(8):1972\u20131985.","journal-title":"Cancer Res"},{"key":"e_1_3_2_178_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1410"},{"key":"e_1_3_2_179_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-869008"},{"key":"e_1_3_2_180_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02141-2"},{"issue":"13","key":"e_1_3_2_181_2","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood.2020007233","article-title":"Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: A phase 1 study","volume":"137","author":"Stein EM","year":"2021","unstructured":"Stein EM, DiNardo CD, Fathi AT, Mims AS, Pratz KW, Savona MR, Stein AS, Stone RM, Winer ES, Seet CS, et al. Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: A phase 1 study. Blood. 2021;137(13):1792\u20131803.","journal-title":"Blood"},{"key":"e_1_3_2_182_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01632"},{"key":"e_1_3_2_183_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.9b00509"},{"key":"e_1_3_2_184_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00362"},{"key":"e_1_3_2_185_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1930"},{"issue":"1","key":"e_1_3_2_186_2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12964-020-00536-7","article-title":"Identification of a selective inhibitor of IDH2\/R140Q enzyme that induces cellular differentiation in leukemia cells","volume":"18","author":"Chen J","year":"2020","unstructured":"Chen J, Yang J, Wei Q, Weng L, Wu F, Shi Y, Cheng X, Cai X, Hu C, Cao P. Identification of a selective inhibitor of IDH2\/R140Q enzyme that induces cellular differentiation in leukemia cells. Cell Commun Signal. 2020;18(1):55.","journal-title":"Cell Commun Signal"},{"key":"e_1_3_2_187_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-05-850826"},{"issue":"13","key":"e_1_3_2_188_2","doi-asserted-by":"crossref","DOI":"10.3390\/nu14132669","article-title":"Hydroxycitric acid inhibits chronic myelogenous leukemia growth through activation of AMPK and mTOR pathway","volume":"14","author":"Verrelli D","year":"2022","unstructured":"Verrelli D, Dallera L, Stendardo M, Monzani S, Pasqualato S, Giorgio M, Pallavi R. Hydroxycitric acid inhibits chronic myelogenous leukemia growth through activation of AMPK and mTOR pathway. Nutrients. 2022;14(13).","journal-title":"Nutrients"},{"issue":"5","key":"e_1_3_2_189_2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3892\/or_00000778","article-title":"A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: Preliminary results","volume":"23","author":"Schwartz L","year":"2010","unstructured":"Schwartz L, Abolhassani M, Guais A, Sanders E, Steyaert JM, Campion F, Isra\u00ebl M. A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: Preliminary results. Oncol Rep. 2010;23(5):1407\u20131416.","journal-title":"Oncol Rep"},{"key":"e_1_3_2_190_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-010-9552-x"},{"issue":"14","key":"e_1_3_2_191_2","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1158\/0008-5472.CAN-09-0536","article-title":"Cucurbitacin B induces apoptosis by inhibition of the JAK\/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells","volume":"69","author":"Thoennissen NH","year":"2009","unstructured":"Thoennissen NH, Iwanski GB, Doan NB, Okamoto R, Lin P, Abbassi S, Song JH, Yin D, Toh M, Xie WD, et al. Cucurbitacin B induces apoptosis by inhibition of the JAK\/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Cancer Res. 2009;69(14):5876\u20135884.","journal-title":"Cancer Res"},{"key":"e_1_3_2_192_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105748","article-title":"Cucurbitacin B inhibits non-small cell lung cancer in\u00a0vivo and in\u00a0vitro by triggering TLR4\/NLRP3\/GSDMD-dependent pyroptosis","volume":"170","author":"Yuan R","year":"2021","unstructured":"Yuan R, Zhao W, Wang QQ, He J, Han S, Gao H, Feng Y, Yang S. Cucurbitacin B inhibits non-small cell lung cancer in\u00a0vivo and in\u00a0vitro by triggering TLR4\/NLRP3\/GSDMD-dependent pyroptosis. Pharmacol Res. 2021;170: Article 105748.","journal-title":"Pharmacol Res"},{"issue":"1","key":"e_1_3_2_193_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13020-022-00581-z","article-title":"Cucurbitacin B inhibits TGF-\u03b21-induced epithelial-mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K\/Akt\/mTOR pathways","volume":"17","author":"Yuan R","year":"2022","unstructured":"Yuan R, Fan Q, Liang X, Han S, He J, Wang QQ, Gao H, Feng Y, Yang S. Cucurbitacin B inhibits TGF-\u03b21-induced epithelial-mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K\/Akt\/mTOR pathways. Chin Med. 2022;17(1):24.","journal-title":"Chin Med"},{"issue":"10","key":"e_1_3_2_194_2","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1016\/j.apsb.2022.05.021","article-title":"Cucurbitacin B-induced G2\/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78-FOXM1-KIF20A pathway","volume":"12","author":"Wei J","year":"2022","unstructured":"Wei J, Chen X, Li Y, Li R, Bao K, Liao L, Xie Y, Yang T, Zhu J, Mao F, et al. Cucurbitacin B-induced G2\/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78-FOXM1-KIF20A pathway. Acta Pharm Sin B. 2022;12(10):3861\u20133876.","journal-title":"Acta Pharm Sin B"},{"issue":"13","key":"e_1_3_2_195_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137130","article-title":"Cucurbitacin B down-regulates TNF receptor 1 expression and inhibits the TNF-\u03b1-dependent nuclear factor \u03baB signaling pathway in human lung adenocarcinoma A549 cells","volume":"23","author":"Kusagawa E","year":"2022","unstructured":"Kusagawa E, Okuda C, Yamaguchi R, Nakano K, Miyake Y, Kataoka T. Cucurbitacin B down-regulates TNF receptor 1 expression and inhibits the TNF-\u03b1-dependent nuclear factor \u03baB signaling pathway in human lung adenocarcinoma A549 cells. Int J Mol Sci. 2022;23(13).","journal-title":"Int J Mol Sci"},{"issue":"1","key":"e_1_3_2_196_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2014.03.015","article-title":"Inactivation of ATP citrate lyase by cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth","volume":"349","author":"Gao Y","year":"2014","unstructured":"Gao Y, Islam MS, Tian J, Lui VW, Xiao D. Inactivation of ATP citrate lyase by cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth. Cancer Lett. 2014;349(1):15\u201325.","journal-title":"Cancer Lett"},{"issue":"6","key":"e_1_3_2_197_2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41419-021-03833-2","article-title":"IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R","volume":"12","author":"Qiao C","year":"2021","unstructured":"Qiao C, Huang W, Chen J, Feng W, Zhang T, Wang Y, Liu D, Ji X, Xie M, Sun M, et al. IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R. Cell Death Dis. 2021;12(6):564.","journal-title":"Cell Death Dis"},{"issue":"2","key":"e_1_3_2_198_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3892\/or.2022.8469","article-title":"Combined inhibition of ACLY and CDK4\/6 reduces cancer cell growth and invasion","volume":"49","author":"Velez BC","year":"2023","unstructured":"Velez BC, Petrella CP, DiSalvo KH, Cheng K, Kravtsov R, Krasniqi D, Krucher NA. Combined inhibition of ACLY and CDK4\/6 reduces cancer cell growth and invasion. Oncol Rep. 2023;49(2):32.","journal-title":"Oncol Rep"},{"issue":"1","key":"e_1_3_2_199_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12020-022-03124-6","article-title":"ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells","volume":"78","author":"Huang SS","year":"2022","unstructured":"Huang SS, Tsai CH, Kuo CY, Li YS, Cheng SP. ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells. Endocrine. 2022;78(1):85\u201394.","journal-title":"Endocrine"},{"key":"e_1_3_2_200_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0870"},{"key":"e_1_3_2_201_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-00160-x"},{"issue":"18","key":"e_1_3_2_202_2","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/0008-5472.CAN-22-0042","article-title":"GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors","volume":"82","author":"Li Y","year":"2022","unstructured":"Li Y, Li B, Xu Y, Qian L, Xu T, Meng G, Li H, Wang Y, Zhang L, Jiang X, et al. GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors. Cancer Res. 2022;82(18):3223\u20133235.","journal-title":"Cancer Res"},{"issue":"13","key":"e_1_3_2_203_2","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-18-3527","article-title":"LKB1 and KEAP1\/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma","volume":"79","author":"Galan-Cobo A","year":"2019","unstructured":"Galan-Cobo A, Sitthideatphaiboon P, Qu X, Poteete A, Pisegna MA, Tong P, Chen PH, Boroughs LK, Rodriguez MLM, Zhang W, et al. LKB1 and KEAP1\/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma. Cancer Res. 2019;79(13):3251\u20133267.","journal-title":"Cancer Res"},{"key":"e_1_3_2_204_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01398"},{"issue":"12","key":"e_1_3_2_205_2","first-page":"1749","article-title":"A combination of glutaminase inhibitor 968 and PD-L1 blockade boosts the immune response against ovarian cancer","volume":"11","author":"Wang JJ","year":"2021","unstructured":"Wang JJ, Siu MK, Jiang YX, Leung TH, Chan DW, Wang HG, Ngan HY, Chan KK. A combination of glutaminase inhibitor 968 and PD-L1 blockade boosts the immune response against ovarian cancer. Biomol Ther. 2021;11(12):1749.","journal-title":"Biomol Ther"},{"key":"e_1_3_2_206_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75836"},{"key":"e_1_3_2_207_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq5925"},{"key":"e_1_3_2_208_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-22-0282"},{"key":"e_1_3_2_209_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00647-3"},{"issue":"1","key":"e_1_3_2_210_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13046-020-01579-x","article-title":"CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling","volume":"39","author":"Gao L","year":"2020","unstructured":"Gao L, Xu Z, Huang Z, Tang Y, Yang D, Huang J, He L, Liu M, Chen Z, Teng Y. CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling. J Exp Clin Cancer Res. 2020;39(1):73.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_2_211_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007146"},{"issue":"13","key":"e_1_3_2_212_2","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1158\/1078-0432.CCR-23-0036","article-title":"Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Preclinical evaluation and phase Ib multicenter clinical trial (BilT-04)","volume":"29","author":"Mohan A","year":"2023","unstructured":"Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, et al. Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Preclinical evaluation and phase Ib multicenter clinical trial (BilT-04). Clin Cancer Res. 2023;29(13):2394\u20132400.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_2_213_2","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.12435"},{"issue":"3","key":"e_1_3_2_214_2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2174\/1871520615666141216150659","article-title":"Targeting mitochondrial citrate transport in breast cancer cell lines","volume":"15","author":"Ozkaya AB","year":"2015","unstructured":"Ozkaya AB, Ak H, Atay S, Aydin HH. Targeting mitochondrial citrate transport in breast cancer cell lines. Anti Cancer Agents Med Chem. 2015;15(3):374\u2013381.","journal-title":"Anti Cancer Agents Med Chem"},{"key":"e_1_3_2_215_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-01022-y"},{"key":"e_1_3_2_216_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-020-0288-x"}],"container-title":["Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.34133\/research.0351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T12:16:22Z","timestamp":1718194582000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.34133\/research.0351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":215,"alternative-id":["10.34133\/research.0351"],"URL":"https:\/\/doi.org\/10.34133\/research.0351","relation":{},"ISSN":["2639-5274"],"issn-type":[{"value":"2639-5274","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"0351"}}